Now known as Alphabet, Google Life Sciences progresses further with smart contact lenses and makes what was once a futuristic concept a reality that will soon come to life. It’s been one of Google’s more ambitious aspirations that has led many to believe it was a farfetched idea, doomed to remain patented, but never truly developed.
However, Novartis healthcare company decided to license the technology so it would one day become available to the public in effort to combat crippling conditions, such as diabetes. According to Google founder and now Alphabet president, Sergey Brin, the project is now full steam ahead with Andy Conrad as the company’s CEO.
The team will be continuing their motivated and innovative work along with other life science companies, by moving concept technologies into reality, from R&D to clinical trials. It is their hope that the tech giant will successfully become partners with many health care companies that will aid the advancement of technology and medicine alike.
And it’s precisely where it seems to be going, with a gathered diverse team of oncologists, engineers and other experts, who will hopefully work together and design better prospects for patients worldwide.
Their Google smart contact lenses project will be aimed at the millions of people suffering from diabetes. The tiny devices will be able to measure glucose levels and send the monitored information directly into the patient’s phone. There are a number of methods available, though none as convenient.
The finger pricking gadgets used by diabetes patients to measure their blood sugar are quite simple in use, but requires blood and can only read the levels at that particular moment. The contact lenses, however, will be keeping a constant monitor on the patient’s need for insulin.
Google Life Sciences also had a similar device in the works, such as glucose monitoring patches that will be both high-tech and low-cost mostly for patients suffering from type 1 diabetes. No word has been released that the merging and transforming into the independent company, Alphabet, will be slowing down their progress.
It has left Sergey Brin as Alphabet President, which had thus paved the way for Sundar Pichai to become CEO of Google, as it was reported by numerous sources earlier this week. The shift will hopefully allow them to afford undivided attention to their goals, and further both medicine and technology at the same time.
Image source: mashable.com